Carmat: surrounded by analysts' comments
Given the company's progress, the lack of alternatives in the field of total artificial hearts, and the sector's colossal needs, we feel that the company is clearly undervalued, with an upside of +215%", believes the analyst.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction